Skip to main content

Table 1 Demographic information

From: Comparison of gait in progressive supranuclear palsy, Parkinson’s disease and healthy older adults

 

PSP(n = 19)

PD(n = 20)

HOA(n = 20)

 

Age, yrs

69.1 (8.7)

68.3 (7.9)

71.8 (4.1)

n/s

Male, n(%)

16 (84)

16 (80)

7 (35)

P = 0.001

Height, cm

170.6 (8.2)

171.8 (8.0)

166.6 (6.3)

n/s

Weight, kg

80.5 (13.5)

78.3 (10.2)

68.4 (11.5)

F 2,56 = 5.9, P = 0.01

Symptom duration, yrs

4.3 (2.7)

6.6 (5.8)

-

n/s

Disease severity

41.7 (17.2)

14.4 (16.7)

-

-

Normalized speed

1.03 (0.27)

1.28 (0.22)

1.54 (0.16)

F 2,56 = 25.8, P < 0.001

Normalized stride length

1.2 (0.2)

1.4 (0.2)

1.6 (0.1)

F 2,56 = 25.6, P < 0.001

Cadence (steps/min)

103.6 (9.3)

109.7 (6.9)

113.4 (7.0)

F 2,56 = 7.9, P = 0.001

Cadence (steps/min)*

119.8 (15.4)

108.9 (18.9)

92.7 (9.5)

F 2,56 = 15.9, P < 0.001

DS (%)*

31.1 (4.6)

27.9 (3.0)

25.6 (2.7)

F 2,56 = 12.2, P < 0.001

Step width (cm)*

11.4 (4.2)

9.0 (2.9)

8.5 (2.9)

F 2,56 = 4.0, P = 0.02

Stance time variability (sec)*

0.024 (0.009)

0.018 (0.008)

0.025 (0.013)

n/s

Stride length variability (cm)*

3.2 (1.7)

2.4 (1.2)

2.8 (1.6)

n/s

  1. Mean (standard deviation, SD) for each group. Disease severity was measured using PSP Rating Scale for PSP participants (0=no symptoms – 100) and Unified Parkinson’s Disease Rating Scale – motor subsection (UPDRS III) for PD participants (0=no symptoms – 56). Mean (SD) normalized speed, normalized stride length and cadence for preferred speed walks. Mean (SD) of other gait parameters for the walk with normalized stride length closest to 1.4.
  2. * Determined from walk with normalized stride length closest to 1.4. PSP progressive supranuclear palsy, PD Parkinson’s disease, HOA healthy older adult, DS double support percentage of gait cycle, n/s not statistically significant.